Centene said it will present at the Bernstein 40th Annual Strategic Decisions Conference on Friday, May 31, 2024 at 8 a.m. Eastern Daylight Time, and will meet with investors afterward.

8-KRegulation FD DisclosureFiled May 29, 2024Period of report May 29, 2024Summary published (UTC) Oct 26, 2026

Key points

AI summary

Centene said it will present at the Bernstein 40th Annual Strategic Decisions Conference on Friday, May 31, 2024 at 8 a.m. Eastern Daylight Time, and will meet with investors afterward.
Centene said it expects to reaffirm its 2024 full-year adjusted diluted earnings per share (EPS) guidance of greater than $6.80 and its full-year consolidated health benefits ratio range of 87.3% to 87.9%.
The company said claims receipts in Medicaid were higher than expected in April, and that its early read of claims for May still showed medical costs running higher than expected in Medicaid. It also said just under 50% of its Medicaid rate changes are expected to take effect between July 1, 2024 and October 1.
The company said its Medicare segment is on track with expectations for April 2024. It also said its adjusted diluted EPS guidance now includes a projected premium deficiency reserve of about $125 million for the Q4 2024 related to 2025 Medicare Advantage bids.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Centene Bernstein conference presentation schedule

Centene said it will present at the Bernstein 40th Annual Strategic Decisions Conference on Friday, May 31, 2024 at 8 a.m. Eastern Daylight Time, and will meet with investors afterward.

Source · Based on the filing body and exhibits

Centene reaffirms full-year outlook

Centene said it expects to reaffirm its 2024 full-year adjusted diluted earnings per share (EPS) guidance of greater than $6.80 and its full-year consolidated health benefits ratio range of 87.3% to 87.9%.

Source · Based on the filing body and exhibits

Medicaid medical costs and rate change timing

The company said claims receipts in Medicaid were higher than expected in April, and that its early read of claims for May still showed medical costs running higher than expected in Medicaid. It also said just under 50% of its Medicaid rate changes are expected to take effect between July 1, 2024 and October 1.

Source · Based on the filing body and exhibits

Medicare segment and premium deficiency reserve

The company said its Medicare segment is on track with expectations for April 2024. It also said its adjusted diluted EPS guidance now includes a projected premium deficiency reserve of about $125 million for the Q4 2024 related to 2025 Medicare Advantage bids.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.